148 related articles for article (PubMed ID: 30516678)
21. Normal uptake of 68Ga-DOTA-TOC by the pancreas uncinate process mimicking malignancy at somatostatin receptor PET.
Jacobsson H; Larsson P; Jonsson C; Jussing E; Grybäck P
Clin Nucl Med; 2012 Apr; 37(4):362-5. PubMed ID: 22391705
[TBL] [Abstract][Full Text] [Related]
22. Influence of PET/CT 68Ga somatostatin receptor imaging on proceeding with patients, who were previously diagnosed with 99mTc-EDDA/HYNIC-TOC SPECT.
Madrzak D; Mikołajczak R; Kamiński G
Nucl Med Rev Cent East Eur; 2016; 19(2):88-92. PubMed ID: 27479886
[TBL] [Abstract][Full Text] [Related]
23. 68Ga-DOTA-TOC Uptake in Pleomorphic Adenoma.
Laurens ST; Netea-Maier RT; Aarntzen EJHG
Clin Nucl Med; 2018 Jul; 43(7):524-525. PubMed ID: 29847321
[TBL] [Abstract][Full Text] [Related]
24. Expression of somatostatin receptors in hemangioblastomas associated with von Hippel-Lindau disease as a novel diagnostic, therapeutic, and follow-up opportunity: A case report and literature review.
Brabo EP; de Almeida SA; Rafful PP; Rosado-de-Castro PH; Vieira Neto L
Arch Endocrinol Metab; 2024 May; 68():e230181. PubMed ID: 38788146
[TBL] [Abstract][Full Text] [Related]
25. 68Ga DOTANOC PET/CT aiding in the diagnosis of von Hippel-Lindau syndrome by detecting cerebellar hemangioblastoma and adrenal pheochromocytoma.
Mukherjee A; Karunanithi S; Bal C; Kumar R
Clin Nucl Med; 2014 Oct; 39(10):920-1. PubMed ID: 24999687
[TBL] [Abstract][Full Text] [Related]
26. Constellation of Von Hippel-Lindau Disease-Related Findings on a 68Ga-DOTATATE PET/CT.
Marcus C; John PD; Giles M; Sethi I
Clin Nucl Med; 2021 Oct; 46(10):829-831. PubMed ID: 34028413
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetic analysis of [
Bashir A; Vestergaard MB; Binderup T; Broholm H; Marner L; Ziebell M; Fugleholm K; Mathiesen T; Kjær A; Law I
Eur J Nucl Med Mol Imaging; 2020 Oct; 47(11):2577-2588. PubMed ID: 32170347
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of (64)Cu-labeled DOTA-D-Phe(1)-Tyr (3)-octreotide ((64)Cu-DOTA-TOC) for imaging somatostatin receptor-expressing tumors.
Hanaoka H; Tominaga H; Yamada K; Paudyal P; Iida Y; Watanabe S; Paudyal B; Higuchi T; Oriuchi N; Endo K
Ann Nucl Med; 2009 Aug; 23(6):559-67. PubMed ID: 19504168
[TBL] [Abstract][Full Text] [Related]
29. Pituitary Adenoma Recurrence Suspected on Central Hyperthyroidism Despite Empty Sella and Confirmed by 68Ga-DOTA-TOC PET/CT.
Gauthé M; Sarfati J; Bourcigaux N; Christin-Maitre S; Talbot JN; Montravers F
Clin Nucl Med; 2017 Jun; 42(6):454-455. PubMed ID: 28263215
[TBL] [Abstract][Full Text] [Related]
30. Functional imaging in differentiating bronchial masses: an initial experience with a combination of (18)F-FDG PET-CT scan and (68)Ga DOTA-TOC PET-CT scan.
Kumar A; Jindal T; Dutta R; Kumar R
Ann Nucl Med; 2009 Oct; 23(8):745-51. PubMed ID: 19784877
[TBL] [Abstract][Full Text] [Related]
31. Multiparametric PET imaging in thyroid malignancy characterizing tumour heterogeneity: somatostatin receptors and glucose metabolism.
Traub-Weidinger T; Putzer D; von Guggenberg E; Dobrozemsky G; Nilica B; Kendler D; Bale R; Virgolini IJ
Eur J Nucl Med Mol Imaging; 2015 Dec; 42(13):1995-2001. PubMed ID: 26173620
[TBL] [Abstract][Full Text] [Related]
32. Positron emission tomography study on pancreatic somatostatin receptors in normal and diabetic rats with 68Ga-DOTA-octreotide: a potential PET tracer for beta cell mass measurement.
Sako T; Hasegawa K; Nishimura M; Kanayama Y; Wada Y; Hayashinaka E; Cui Y; Kataoka Y; Senda M; Watanabe Y
Biochem Biophys Res Commun; 2013 Dec; 442(1-2):79-84. PubMed ID: 24220338
[TBL] [Abstract][Full Text] [Related]
33. Simultaneous (68)Ga-DOTA-TOC PET/MRI with gadoxetate disodium in patients with neuroendocrine tumor.
Hope TA; Pampaloni MH; Nakakura E; VanBrocklin H; Slater J; Jivan S; Aparici CM; Yee J; Bergsland E
Abdom Imaging; 2015 Aug; 40(6):1432-40. PubMed ID: 25820755
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic performance and impact on patient management of
Paquet M; Gauthé M; Zhang Yin J; Nataf V; Bélissant O; Orcel P; Roux C; Talbot JN; Montravers F
Eur J Nucl Med Mol Imaging; 2018 Sep; 45(10):1710-1720. PubMed ID: 29532101
[TBL] [Abstract][Full Text] [Related]
35. Suprasellar Hemangioblastoma on 68 Ga-DOTATATE PET/CT.
Filizoglu N; Ozguven S
Clin Nucl Med; 2022 Nov; 47(11):e700-e701. PubMed ID: 35695763
[TBL] [Abstract][Full Text] [Related]
36. 68Ga-DOTATOC PET/CT Imaging in Solitary Fibrous Tumor of the Pleura.
Lococo F; Rapicetta C; Casali M; Bellafiore S; Rossi G; Treglia G; Gasparini E; Paci M
Clin Nucl Med; 2017 Jun; 42(6):e294-e296. PubMed ID: 28368890
[TBL] [Abstract][Full Text] [Related]
37. Long-axial field-of-view PET/CT for the assessment of inflammation in calcified coronary artery plaques with [
Mingels C; Sari H; Gözlügöl N; Bregenzer C; Knappe L; Krieger K; Afshar-Oromieh A; Pyka T; Nardo L; Gräni C; Alberts I; Rominger A; Caobelli F
Eur J Nucl Med Mol Imaging; 2024 Jan; 51(2):422-433. PubMed ID: 37740742
[TBL] [Abstract][Full Text] [Related]
38. Somatostatin receptor based PET/CT imaging with 68Ga-DOTA-Nal3-octreotide for localization of clinically and biochemically suspected insulinoma.
Sharma P; Arora S; Karunanithi S; Khadgawat R; Durgapal P; Sharma R; Kandasamy D; Bal C; Kumar R
Q J Nucl Med Mol Imaging; 2016 Mar; 60(1):69-76. PubMed ID: 24740163
[TBL] [Abstract][Full Text] [Related]
39. Somatostatin receptor imaging in non-(131)I-avid metastatic differentiated thyroid carcinoma for determining the feasibility of peptide receptor radionuclide therapy with (177)Lu-DOTATATE: low fraction of patients suitable for peptide receptor radionuclide therapy and evidence of chromogranin A level-positive neuroendocrine differentiation.
Jois B; Asopa R; Basu S
Clin Nucl Med; 2014 Jun; 39(6):505-10. PubMed ID: 24662668
[TBL] [Abstract][Full Text] [Related]
40. Comparison of (68)Ga-DOTA-Tyr(3)-octreotide and (18)F-fluoro-L-dihydroxyphenylalanine positron emission tomography in neuroendocrine tumor patients.
Putzer D; Gabriel M; Kendler D; Henninger B; Knoflach M; Kroiss A; Vonguggenberg E; Warwitz B; Virgolini IJ
Q J Nucl Med Mol Imaging; 2010 Feb; 54(1):68-75. PubMed ID: 20168288
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
